Dernières nouvelles pour Polar Power (NASDAQ:POLA) Stock

Polar Power

Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.

Polar Power Inc

POLAR CAP GLOBAL FNCL TR by POLAR CAP GLOBAL FINANCIALS TR PLC

POLAR CAPITAL TECH TR NEW by Polar Capital Technology Trust Plc.

POLAR CAPITAL TECH TR PLC by Polar Capital Technology Trust Plc.

POLAR PETROLEUM CORP by Polar Petroleum Corp.

POLA ORBIS HOLDINGS INC by Pola Orbis Holdings Inc

Pola Orbis Holdings Inc

POLAR CAPITAL HOLDING ORD by Polar Capital Holdings PLC

Polar Capital Holdings PLC

PolarX Ltd

POLAREAN IMAGING LTD by Polarean Imaging Ltd.

Polarean Imaging PLC

POLARIS HLDGS CO LTD by POLARIS HLDGS CO LTD

Polaris Holdings Co Ltd

Polaris Inc

POLARIS INTL HOLDINGS INC by Polaris International Holdings, Inc.

Polaris International Holdings Inc

Polaris Northstar Capital Corp

POLARIS NORTHSTAR CAP CRP by POLARIS NORTHSTAR CAP CORP.

POLARIS RENEWABLE ENERGY by POLARIS RENEWABLE ENERGY INC.

Polaris Renewable Energy Inc

PolarityTE Inc

Identiv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INVE#NASDAQ">INVE</a>) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.22) by 4.55 percent. This is a 12.5 percent increase over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $5.27 million which beat the analyst consensus estimate of $4.95 million by 6.44 percent. This is a 20.86 percent decrease over sales of $6.66 million the same period last year.

Earnings

Earnings Beats

News

INVE

Identiv Q1 GAAP EPS $(0.21) Beats $(0.22) Estimate, Sales $5.27M Beat $4.95M Estimate

Texas Pacific Land (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPL#NYSE">TPL</a>) reported quarterly earnings of $5.24 per share. This is a 5.43 percent increase over earnings of $4.97 per share from the same period last year. The company reported quarterly sales of $195.98 million which missed the analyst consensus estimate of $211.00 million by 7.12 percent. This is a 12.54 percent increase over sales of $174.14 million the same period last year.

Earnings Misses

Texas Pacific Land Q1 EPS $5.24 Up From $4.97 YoY, Sales $195.98M Miss $211.00M Estimate

- Breakthrough Therapy Designation request based on veligrotug's (i) consistent and robust improvement and resolution of diplopia in chronic TED, and (ii) rapid onset of proptosis response -
- Veligrotug met all of its primary and secondary endpoints in the pivotal THRIVE and THRIVE-2 clinical trials in active and chronic TED -
- First and only drug candidate in chronic TED to demonstrate statistically significant and clinically meaningful improvement and resolution of diplopia in a global phase 3 clinical trial -
- Breakthrough Therapy Designation supports eligibility for Priority Review -
- Biologics License Application (BLA) submission for veligrotug on track for second half 2025 with a planned U.S. launch in 2026, if approved -

Biotech

General

VRDN

Viridian Therapeutics Receives FDA Breakthrough Therapy Designation For Veligrotug For Thyroid Eye Disease

Zillow Gr Q1 Adj. EPS $0.41 Beats $0.38 Estimate, Sales $598.00M Beat $587.58M Estimate

Dividends

Buybacks

QGEN

QIAGEN At Annual General Meeting Proposes To Introduce A Dividend As Expansion Of Capital Allocation Strategy, Also Seek Authorization For A New $500M Share Repurchase

SITE Centers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SITC#NYSE">SITC</a>) reported quarterly earnings of $0.16 per share which missed the analyst consensus estimate of $0.18 by 11.11 percent. This is a 85.71 percent decrease over earnings of $1.12 per share from the same period last year. The company reported quarterly sales of $40.34 million which beat the analyst consensus estimate of $28.89 million by 39.65 percent. This is a 66.55 percent decrease over sales of $120.62 million the same period last year.

SITC

SITE Centers Q1 FFO $0.16 Misses $0.18 Estimate, Sales $40.34M Beat $28.89M Estimate

ADMA Biologics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADMA#NASDAQ">ADMA</a>) FY2026 Revenue expected to be more than $625.00M vs $629.23M Est

Guidance

ADMA

ADMA Biologics FY2026  Revenue expected to be more than $625.00M vs $629.23M Est

Houlihan Lokey (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLI#NYSE">HLI</a>) reported quarterly earnings of $1.96 per share which beat the analyst consensus estimate of $1.62 by 20.99 percent. This is a 54.33 percent increase over earnings of $1.27 per share from the same period last year. The company reported quarterly sales of $666.42 million which beat the analyst consensus estimate of $629.32 million by 5.90 percent. This is a 28.05 percent increase over sales of $520.46 million the same period last year.

Houlihan Lokey Q4 Adj. EPS $1.96 Beats $1.62 Estimate, Sales $666.42M Beat $629.32M Estimate

BGSF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BGSF#NYSE">BGSF</a>) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $(0.11) by 163.64 percent. This is unchanged from the same period last year. The company reported quarterly sales of $63.23 million which missed the analyst consensus estimate of $65.25 million by 3.09 percent. This is a 8.04 percent decrease over sales of $68.77 million the same period last year.

BGSF

BGSF Q1 Adj. EPS $0.07 Beats $(0.11) Estimate, Sales $63.23M Miss $65.25M Estimate

Genpact (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/G#NYSE">G</a>) reported quarterly earnings of $0.84 per share which beat the analyst consensus estimate of $0.79 by 6.33 percent. This is a 15.07 percent increase over earnings of $0.73 per share from the same period last year. The company reported quarterly sales of $1.21 billion which met the analyst consensus estimate. This is a 7.32 percent increase over sales of $1.13 billion the same period last year.

Genpact Q1 Adj. EPS $0.84 Beats $0.79 Estimate, Sales $1.21B Inline

ADMA Biologics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADMA#NASDAQ">ADMA</a>) FY2025 Revenue expected to be more than $500.00M vs $495.10M Est

ADMA Biologics FY2025  Revenue expected to be more than $500.00M vs $495.10M Est

BBB Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TBBB#NYSE">TBBB</a>) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.06 by 33.33 percent. The company reported quarterly sales of $836.87 million which beat the analyst consensus estimate of $799.73 million by 4.64 percent.

TBBB

BBB Foods Q1 EPS $0.04 Misses $0.06 Estimate, Sales $836.87M Beat $799.73M Estimate

RenaissanceRe Renews Share Repurchase Program

ADMA Biologics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADMA#NASDAQ">ADMA</a>) reported quarterly earnings of $0.14 per share which missed the analyst consensus estimate of $0.16 by 12.5 percent. This is a 75 percent increase over earnings of $0.08 per share from the same period last year. The company reported quarterly sales of $114.80 million which missed the analyst consensus estimate of $116.40 million by 1.37 percent. This is a 40.22 percent increase over sales of $81.88 million the same period last year.

ADMA Biologics Q1 Adj. EPS $0.14 Misses $0.16 Estimate, Sales $114.80M Miss $116.40M Estimate

Civitas Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIVI#NYSE">CIVI</a>) reported quarterly earnings of $1.77 per share which beat the analyst consensus estimate of $1.65 by 7.27 percent. This is a 0.56 percent decrease over earnings of $1.78 per share from the same period last year. The company reported quarterly sales of $1.19 billion which missed the analyst consensus estimate of $1.20 billion by 0.25 percent. This is a 10.16 percent decrease over sales of $1.33 billion the same period last year.

CIVI

Civitas Resources Q1 Adj. EPS $1.77 Beats $1.65 Estimate, Sales $1.19B Miss $1.20B Estimate

Pitney Bowes Affirms FY2025 Adj EPS Guidance of $1.10-$1.30 vs $1.20 Est; Affirms FY2025 Sales Guidance of $1.95B-$2.00B vs $1.98B Est

NCR Atleos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NATL#NYSE">NATL</a>) affirms FY2025 Adj EPS guidance from $3.22 to $3.22 vs $4.01 analyst estimate. Affirms FY2025 sales outlook from $4.32 billion to $4.32 billion vs $4.30 billion estimate.

NATL

NCR Atleos Affirms FY2025 Adj EPS Guidance of $3.22 vs $4.01 Est; Affirms FY2025 Sales Guidance of $4.32B vs $4.30B Est

DevvStream Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DEVS#NASDAQ">DEVS</a>) shares are trading higher by 107% to 40 cents Wednesday afternoon after the company signed a Memorandum of Understanding with UAE-based Fayafi Investment Holding to form a new joint venture called Fayafi x DevvStream Green Ventures.
What to Know: The <a href="https://www.devvstream.com/news/news-releases/devvstream-corp-and-fayafi-investment-holding-sign-mou-to-explore-creation-of-fayafi-x-devvstream-green-ventures-to-accelerate-global-sustainability-investments">proposed entity</a> aims to invest in global decarbonization and climate infrastructure projects. The venture would combine DevvStream's technical and operational capabilities with Fayafi's capital and institutional network, with an initial funding commitment of $100 million.
Firm agreements are anticipated in the second quarter of 2025, with project rollouts <a href="https://www.devvstream.com/news/news-releases/devvstream-corp-and-fayafi-investment-holding-sign-mou-to-explore-creation-of-fayafi-x-devvstream-green-ventures-to-accelerate-global-sustainability-investments">expected</a> to begin in the latter half of the year.
Read Also: <a href="https://www.benzinga.com/25/05/45262504/super-micro-computer-stock-is-tumbling-wednesday-whats-going-on">Super Micro Computer Stock Is Tumbling Wednesday: What&#8217;s Going On?</a>
What Else: The joint venture will be independently structured, with Fayafi holding 80% ownership and DevvStream 20%, reflecting their respective roles as financial sponsor and technical operator. 
Under the MoU, DevvStream will manage project development, carbon asset structuring and credit monetization, while Fayafi will provide financial backing and facilitate regulatory access. 
The agreement also grants DevvStream exclusivity during the feasibility stage and first rights on carbon-related projects.
DEVS Price Action: According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, DevvStream has a 52-week high of $3 and a 52-week low of 18 cents.
Read Also: • <a href="https://www.benzinga.com/news/earnings/25/05/45260347/crowdstrike-stock-is-sliding-wednesday-whats-going-on">CrowdStrike Stock Is Sliding Wednesday: What&#8217;s Going On?</a>
Photo: Shutterstock

Movers

Trading Ideas

DEVS

DevvStream (DEVS) Stock Is Up 107% Wednesday: What's Going On?

Zillow Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/Z#NASDAQ">Z</a>) reported quarterly sales of $598.00 million which beat the analyst consensus estimate of $586.54 million by 1.95 percent. This is a 13.04 percent increase over sales of $529.00 million the same period last year.

Zillow Gr Q1 Sales $598.00M Beat $586.54M Estimate

2seventy bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSVT#NASDAQ">TSVT</a>) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.12) by 108.33 percent. This is a 101.23 percent increase over losses of $(0.81) per share from the same period last year. The company reported quarterly sales of $22.94 million which beat the analyst consensus estimate of $13.96 million by 64.28 percent. This is a 84.46 percent increase over sales of $12.44 million the same period last year.

Comments

Polar Power

Actualités

Dernières nouvelles pour Polar Power (NASDAQ:POLA) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL